Uncertainties in the Prevention and Treatment of Glucocorticoid-induced Osteoporosis

Overview

Journal J Bone Miner Res

Publisher Oxford University Press

Date 2011 Jul 2

PMID 21721042

Citations 19

Authors

Karen E Hansen

H Alexander Wilson

Carol Zapalowski

Howard A Fink

Salvatore Minisola

Robert A Adler

Affiliations

Soon will be listed here.

Abstract

Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoid-induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and update the GIO guidelines [Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-1526]. Herein, we review the new guidelines for JBMR readers, highlighting the changes introduced by the 2010 publication. We discuss several patient scenarios for which the new treatment guidelines do not apply, or for which our committee interprets existing literature differently and suggests an alternative approach.

Citing Articles

Wang L, Chen L, Chen K Int J Mol Sci. 2023; 24(6).

PMID: 36982891 PMC: 10054048. DOI: 10.3390/ijms24065814.

Acute exacerbation of COPD increases the risk of hip fractures: a nested case-control study from the Korea National Health Insurance Service.

Gu K, Yoon S, Jung S, Baek M, Kim W, Jung J Korean J Intern Med. 2022; 37(3):631-638.

PMID: 35124940 PMC: 9082449. DOI: 10.3904/kjim.2021.152.

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis.

Minisola S, Cipriani C, Della Grotta G, Colangelo L, Occhiuto M, Biondi P Ther Adv Musculoskelet Dis. 2019; 11:1759720X19877994.

PMID: 31632472 PMC: 6778993. DOI: 10.1177/1759720X19877994.

New anabolic therapies for osteoporosis.

Minisola S, Cipriani C, Occhiuto M, Pepe J Intern Emerg Med. 2017; 12(7):915-921.

PMID: 28780668 DOI: 10.1007/s11739-017-1719-4.

Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.

Mazziotti G, Formenti A, Adler R, Bilezikian J, Grossman A, Sbardella E Endocrine. 2016; 54(3):603-611.

PMID: 27766553 DOI: 10.1007/s12020-016-1146-8.